Allogene Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Allogene Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.32 | $-0.33 | 3.03 % |
Jun 2024 | 2024-08-07 | $-0.35 | $-0.35 | 0.00 % |
Mar 2024 | 2024-05-13 | $-0.38 | $-0.41 | 7.32 % |
Dec 2023 | 2024-03-14 | $-0.43 | $-0.45 | 4.44 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $0 | $10.00K | -100.0 % |
Jun 2024 | 2024-08-07 | $0 | $20.00K | -100.0 % |
Mar 2024 | 2024-05-13 | $22.00K | $10.00K | 120.0 % |
Dec 2023 | 2024-03-14 | $21.00K | $20.00K | 5.00 % |
Allogene Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Allogene Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.32, which beat the estimate of $-0.33.
Allogene Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which missed the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.